Events

Since the pandemic struck last March, pharmacists have faced a multitude of challenges as they strive to maintain continuity of care. One change meant to help pharmacists better manage patients’ drug therapy is the federal government’s decision to issue a short-term subsection 56(1) exemption from the Controlled Drugs and Substances Act (CDSA). And pharmacists are pushing hard to make the exemption permanent.